Clinical Trials
67 trialsABC
University of California, San Francisco
uPARCRPC
Rigshospitalet, Denmark
DNA Methylation in Adenocarcinoma of the Prostate: Analysis of Validated Biomarkers in Urine
Mayo Clinic
GENTleMEN
University of Washington
Collection of Blood in Studying Metabolites in Patients With Prostate Cancer
University of Southern California
Registry to Evaluate Long-Term Outcomes in Patients Who Undergo 68-Ga-PSMA-11 PET/CT Imaging Evaluations
Telix Pharmaceuticals (Innovations) Pty Limited
Study of Rates of Prostate Cancer Diagnosis in Men of African Ancestry Using MRI and MRI Guided Biopsy
National Institutes of Health Clinical Center (CC)
Characterizing Fatigue Experienced by Cancer Patients Receiving Primary Treatment and Cancer Survivors
National Institutes of Health Clinical Center (CC)
Genetic Evaluation of Men (GEM)
Thomas Jefferson University
Associations Between Chemotherapy-Induced Nausea in Patients With Genitourinary, Sarcoma or Melanoma Cancers and Changes in Gut Microbiome: Potential for Precision Therapeutics
Mayo Clinic
ES-HIFU
EDAP TMS S.A.
PSMA-PET/CT Registry
AHS Cancer Control Alberta
pCHIP: Prostate Cancer Health Impact Program
Weill Medical College of Cornell University
Immune PDX
Duke University
Health Literacy in Understanding Radiation Therapy Information in Patients Undergoing Definitive Radiation Therapy
University of Southern California
PET-PSMA
Latin American Cooperative Oncology Group
Determination of the Diagnostic Detection Rate of Axumin (Fluciclovine) Digital PET/CT, Post-prostatectomy
University of Vermont
CHARTER
Angle plc
In Situ Clonal Heterogeneity in Prostatic Diagnostic Biopsies
Clinica Luganese Moncucco
An Electronic Registry to Improve Adherence to Active Surveillance Monitoring at a Safety-net Hospital
University of California, San Francisco
Long-term Study to Evaluate and Clinical Outcomes in Patients With Favorable Intermediate Risk Localized Prostate Cancer
Myriad Genetic Laboratories, Inc.
Transrectal Photoacoustic Imaging of the Prostate
Stanford University
P-PROVE
Myriad Genetic Laboratories, Inc.
ExoDx Prostate Evaluation in Prior Negative Prostate Biopsy Setting
Exosome Diagnostics, Inc.
Glycosylation of Exosomes in Prostate and Urothelial Carcinoma
Indiana University
Adaptation of an eHealth (Web-application) Platform for Delivery of a Sedentary Behavior Intervention Among Prostate Cancer Patients
Wake Forest University Health Sciences
Post-marketing Surveillance Regarding Efficacy and Safety of SpaceOARâ„¢
CS Diagnostics GmbH
Assessment of 3D Transperineal Ultrasound Imaging w/ Matrix Array Transducers in Prostate Radiotherapy
Stanford University
Collecting and Storing Blood and Tumor Tissue Samples From Patients Undergoing Prostatectomy or Transurethral Resection of the Prostate
Rutgers, The State University of New Jersey
Cell-Free DNA and RNA in Blood fromMetastatic Prostate Cancer Patients
University of Southern California
Outcome Assessment of an Active Surveillance Program for Low Risk Prostate Cancer: An Observational Study
St. Joseph Hospital of Orange
Circulating Tumor Cells in Prostate Cancer Patients
University of Texas Southwestern Medical Center
PROUD
Duke University
Evaluation of a Blood Biomarker to Try and Distinguish Between the Presence or Absence of Aggressive Prostate Cancer
Genomic Health®, Inc.
Analysis of Cell-free DNA (cfDNA) in Men With Elevated PSA Levels
Chronix Biomedical Corporation
PRIME
Dendreon
Efficacy of Cancer Support Programs: A Social Comparison Theory Analysis
M.D. Anderson Cancer Center
N1
CureOne
Bio-Prost
University Hospital, Grenoble
Measuring the Effect of Radiation Therapy on Patient Activity Levels
University of Pittsburgh
PASCUAL
MDx Health
Evaluation of the NantHealth GPS Cancer Test in Patients With Advanced Cancers
Cota Inc.
Feasibility Study of Tumor Blood Flow Measurement by Detection of Positron Activation Post Proton Therapy (DS01)
University of Florida
Soft Tissue Detection on MRI, Cone Beam CT and Fan Beam CT and Integration of Functional MRI
Virginia Commonwealth University
Prostatectomy Prospective Database
Corewell Health East
MRI Before Biopsy in Diagnosing Patients With Prostate Cancer
Case Comprehensive Cancer Center
Registry to Measure the Impact of Adding Genomic Testing
Myriad Genetic Laboratories, Inc.
Plasma and Urine Samples From Patients With Hormone-Refractory Prostate Cancer Enrolled on Clinical Trials CALGB-9480 or CALGB-9583
Alliance for Clinical Trials in Oncology
Molecular Characterization of CTCs and ctDNA in Blood and Plasma Samples From Patients With Metastatic and/or Hormone-Resistant Prostate Cancer
University of Southern California
PROFUGO
Barwon Health